News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
384,797 Results
Type
Article (25081)
Company Profile (29)
Press Release (359684)
Multimedia
Podcasts (104)
Webinars (13)
Section
Business (121645)
Career Advice (1514)
Deals (18326)
Drug Delivery (60)
Drug Development (43787)
Employer Resources (109)
FDA (9115)
Job Trends (8709)
News (195863)
Policy (18012)
Tag
Academia (1597)
Academic (1)
Accelerated approval (7)
Adcomms (14)
Allergies (80)
Alliances (33594)
ALS (86)
Alzheimer's disease (933)
Antibody-drug conjugate (ADC) (128)
Approvals (9240)
Artificial intelligence (264)
Autoimmune disease (44)
Automation (21)
Bankruptcy (179)
Best Places to Work (7266)
BIOSECURE Act (6)
Biosimilars (89)
Biotechnology (23)
Bladder cancer (92)
Brain cancer (25)
Breast cancer (314)
Cancer (2485)
Cardiovascular disease (198)
Career advice (1302)
Career pathing (26)
CAR-T (126)
CDC (30)
Cell therapy (392)
Cervical cancer (20)
Clinical research (36851)
Collaboration (975)
Compensation (217)
Complete response letters (20)
COVID-19 (1583)
CRISPR (52)
C-suite (307)
Cystic fibrosis (74)
Data (3085)
Decentralized trials (2)
Denatured (35)
Depression (58)
Diabetes (284)
Diagnostics (3568)
Digital health (24)
Diversity (7)
Diversity, equity & inclusion (35)
Drug discovery (122)
Drug pricing (79)
Drug shortages (20)
Duchenne muscular dystrophy (136)
Earnings (56936)
Editorial (35)
Employer branding (14)
Employer resources (96)
Events (57578)
Executive appointments (538)
FDA (10717)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (1)
Frontotemporal dementia (9)
Funding (682)
Gene editing (101)
Generative AI (28)
Gene therapy (347)
GLP-1 (540)
Government (2559)
Grass and pollen (5)
Guidances (290)
Healthcare (10771)
HIV (35)
Huntington's disease (22)
IgA nephropathy (42)
Immunology and inflammation (125)
Immuno-oncology (8)
Indications (41)
Infectious disease (1721)
Inflammatory bowel disease (111)
Inflation Reduction Act (11)
Influenza (56)
Intellectual property (116)
Interviews (275)
IPO (8621)
IRA (30)
Job creations (1774)
Job search strategy (1070)
Kidney cancer (7)
Labor market (38)
Layoffs (245)
Leadership (27)
Legal (4698)
Liver cancer (42)
Longevity (9)
Lung cancer (369)
Lymphoma (178)
Machine learning (16)
Management (37)
Manufacturing (353)
MASH (94)
Medical device (6921)
Medtech (6936)
Mergers & acquisitions (10320)
Metabolic disorders (677)
Multiple sclerosis (92)
NASH (9)
Neurodegenerative disease (112)
Neuropsychiatric disorders (24)
Neuroscience (1514)
NextGen: Class of 2025 (3612)
Non-profit (3010)
Now hiring (9)
Obesity (297)
Opinion (185)
Ovarian cancer (67)
Pain (86)
Pancreatic cancer (101)
Parkinson's disease (128)
Partnered (14)
Patents (233)
Patient recruitment (164)
Peanut (32)
People (29541)
Pharmaceutical (10)
Pharmacy benefit managers (12)
Phase I (10974)
Phase II (15690)
Phase III (13206)
Pipeline (2078)
Policy (146)
Postmarket research (1710)
Preclinical (4814)
Press Release (31)
Prostate cancer (163)
Psychedelics (23)
Radiopharmaceuticals (160)
Rare diseases (401)
Real estate (2636)
Recruiting (41)
Regulatory (12796)
Reports (21)
Research institute (1444)
Resumes & cover letters (229)
Rett syndrome (12)
RNA editing (8)
RSV (47)
Schizophrenia (82)
Series A (119)
Series B (73)
Service/supplier (3)
Sickle cell disease (51)
Special edition (11)
Spinal muscular atrophy (91)
Sponsored (22)
Startups (1608)
State (1)
Stomach cancer (10)
Supply chain (46)
Tariffs (37)
The Weekly (68)
Vaccines (609)
Venture capital (33)
Weight loss (189)
Women's health (34)
Worklife (14)
Date
Today (82)
Last 7 days (488)
Last 30 days (1601)
Last 365 days (19498)
2025 (15646)
2024 (20752)
2023 (22922)
2022 (29034)
2021 (31048)
2020 (30223)
2019 (26485)
2018 (19631)
2017 (18154)
2016 (17800)
2015 (20210)
2014 (16871)
2013 (14759)
2012 (14543)
2011 (14055)
2010 (13211)
Location
Africa (569)
Alabama (52)
Alaska (5)
Arizona (104)
Arkansas (7)
Asia (22339)
Australia (3718)
California (5372)
Canada (1736)
China (506)
Colorado (259)
Connecticut (279)
Delaware (164)
Europe (53047)
Florida (903)
Georgia (197)
Idaho (24)
Illinois (415)
India (29)
Indiana (303)
Iowa (7)
Japan (225)
Kansas (69)
Kentucky (13)
Louisiana (6)
Maine (30)
Maryland (731)
Massachusetts (4049)
Michigan (173)
Minnesota (251)
Missouri (46)
Montana (10)
Nebraska (10)
Nevada (64)
New Hampshire (32)
New Jersey (1776)
New Mexico (13)
New York (1582)
North Carolina (790)
North Dakota (5)
Northern California (2482)
Ohio (153)
Oklahoma (15)
Oregon (20)
Pennsylvania (1208)
Puerto Rico (4)
Rhode Island (23)
South America (771)
South Carolina (24)
Southern California (2135)
Tennessee (100)
Texas (811)
United States (20233)
Utah (173)
Virginia (123)
Washington D.C. (53)
Washington State (456)
West Virginia (2)
Wisconsin (46)
Wyoming (1)
384,797 Results for "ernst and young llp".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Vivex Biologics, Inc. Executive Chair Nominated for Ernst & Young LLP Entrepreneur of the Year® 2025 Florida Award
May 16, 2025
·
3 min read
Press Releases
Terray Therapeutics Expands Board of Directors with Appointment of Biotechnology Leader Wendy Young, Ph.D.
Dr. Young brings more than 30 years of drug discovery leadership and expertise, as Terray’s AI-driven internal and partnered programs continue to accelerate toward patients in need
September 23, 2025
·
2 min read
Business
Aurion Biotech CEO Greg Kunst Named Ernst & Young 2024 Entrepreneur of the Year Mountain West Region
Aurion Biotech, whose mission is to restore vision to millions of patients with life-changing regenerative therapies, announced that CEO Greg Kunst has been named winner of the Ernst & Young 2024 Entrepreneur of the Year award for the Mountain West Region.
June 17, 2024
·
3 min read
Lone Star Bio
Castle Biosciences’ Founder, President and CEO Derek Maetzold Named an EY Entrepreneur Of The Year® 2024 Gulf South Award Winner
Castle Biosciences, Inc., a company improving health through innovative tests that guide patient care, announced that its founder, president and chief executive officer, Derek Maetzold, has been named by Ernst & Young LLP as an Entrepreneur Of The Year® 2024 Gulf South Award winner.
June 14, 2024
·
5 min read
Press Releases
Evkeeza® (evinacumab-dgnb) ANGPTL3 Antibody Approved in the U.S. for Children as Young as 1 Year Old with Ultra-Rare Form of High Cholesterol
September 29, 2025
·
14 min read
Press Releases
Novartis receives approval for first malaria medicine for newborn babies and young infants
July 8, 2025
·
8 min read
Press Releases
Girard Sharp LLP and Motley Rice LLC Announce Proposed Settlements in In re Xyrem (Sodium Oxybate) Antitrust Litigation
May 27, 2025
·
3 min read
Press Releases
STX PARTNERS LLP and Newlin Investment Co. Exercise Warrants of Sharp Therapeutics Corp.
April 21, 2025
·
3 min read
Press Releases
Scott+Scott Attorneys at Law LLP Announce a Notice of Pendency of Class Action in the Acadia Pharmaceuticals, Inc. Securities Litigation
May 19, 2025
·
3 min read
BioMidwest
Lifecore Biomedical Announces Pending Change of Auditor and Provides Expectation for Business Update
Lifecore Biomedical, Inc. announced that Ernst & Young LLP, the Company’s independent registered public accounting firm for the fiscal year ended May 28, 2023, determined that it declined to stand for reappointment as the Company’s independent registered public accounting firm for the Company’s fiscal year ending May 26, 2024 following the filing of the Company’s Annual Report on Form 10-K.
March 26, 2024
·
2 min read
1 of 38,480
Next
